Morgan Stanley analyst Cecilia Furlong downgraded Embecta to Underweight from Equal Weight.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on EMBC:
- Embecta Corp. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
- Embecta sees FY23 adjusted EPS $1.75-$2.00, consensus $3.11
- Embecta reports Q4 EPS (30c), consensus 66c
- embecta Announces Quarterly Cash Dividend
- embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference